1. Home
  2. ALUR vs HOOK Comparison

ALUR vs HOOK Comparison

Compare ALUR & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • HOOK
  • Stock Information
  • Founded
  • ALUR 2009
  • HOOK 2011
  • Country
  • ALUR United States
  • HOOK United States
  • Employees
  • ALUR N/A
  • HOOK N/A
  • Industry
  • ALUR
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALUR
  • HOOK Health Care
  • Exchange
  • ALUR Nasdaq
  • HOOK Nasdaq
  • Market Cap
  • ALUR 19.1M
  • HOOK 18.1M
  • IPO Year
  • ALUR N/A
  • HOOK 2019
  • Fundamental
  • Price
  • ALUR $3.10
  • HOOK $0.85
  • Analyst Decision
  • ALUR Strong Buy
  • HOOK Buy
  • Analyst Count
  • ALUR 3
  • HOOK 4
  • Target Price
  • ALUR $22.83
  • HOOK $10.67
  • AVG Volume (30 Days)
  • ALUR 4.1M
  • HOOK 52.5K
  • Earning Date
  • ALUR 05-13-2025
  • HOOK 05-08-2025
  • Dividend Yield
  • ALUR N/A
  • HOOK N/A
  • EPS Growth
  • ALUR N/A
  • HOOK N/A
  • EPS
  • ALUR N/A
  • HOOK N/A
  • Revenue
  • ALUR $32,110,000.00
  • HOOK $43,946,000.00
  • Revenue This Year
  • ALUR N/A
  • HOOK N/A
  • Revenue Next Year
  • ALUR $38.86
  • HOOK N/A
  • P/E Ratio
  • ALUR N/A
  • HOOK N/A
  • Revenue Growth
  • ALUR N/A
  • HOOK 118.32
  • 52 Week Low
  • ALUR $2.15
  • HOOK $0.82
  • 52 Week High
  • ALUR $98.75
  • HOOK $10.50
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 46.93
  • HOOK 20.10
  • Support Level
  • ALUR $2.72
  • HOOK $1.17
  • Resistance Level
  • ALUR $3.45
  • HOOK $1.24
  • Average True Range (ATR)
  • ALUR 0.41
  • HOOK 0.09
  • MACD
  • ALUR 0.15
  • HOOK -0.01
  • Stochastic Oscillator
  • ALUR 44.04
  • HOOK 6.65

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Share on Social Networks: